GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

The much hyped weightloss drug Wegovy, also marketed as Ozempic, is expected to be in high demand when it becomes available in New Zealand from tomorrow. But the drug is unfunded so users hoping to ...

The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, official data revealed more than 100 deaths in the United Kingdom had now ...